CD80 and neoplasm: Introduction of the B7-1 gene into TAP-deficient tumor cells stimulates immune system to generate stronger T-cell mediated immune responses against B7-1 negative parental counterparts [10]–[12], suggesting that the induction phase of T-cell immunity is augmented by B7-1.